Sharma M, Marin M, Wu H, Prikryl D, Melikyan G
ACS Nano. 2023; 17(17):17436-17450.
PMID: 37589658
PMC: 10510587.
DOI: 10.1021/acsnano.3c05508.
Abisi H, Otieno L, Irungu E, Onyambu F, Chepchirchir A, Anzala O
Medicine (Baltimore). 2023; 101(49):e32024.
PMID: 36626483
PMC: 9750520.
DOI: 10.1097/MD.0000000000032024.
Caillet C, Stofberg M, Muleya V, Shonhai A, Zininga T
Front Mol Biosci. 2022; 9:938099.
PMID: 36032680
PMC: 9411049.
DOI: 10.3389/fmolb.2022.938099.
Ma T, McGregor M, Giron L, Xie G, George A, Abdel-Mohsen M
Elife. 2022; 11.
PMID: 35787792
PMC: 9255966.
DOI: 10.7554/eLife.78870.
Weichseldorfer M, Tagaya Y, Reitz M, DeVico A, Latinovic O
J Transl Med. 2022; 20(1):39.
PMID: 35073923
PMC: 8785515.
DOI: 10.1186/s12967-022-03243-8.
Uptake of Biotinylated Spermine in Astrocytes: Effect of Cx43 siRNA, HIV-Tat Protein and Polyamine Transport Inhibitor on Polyamine Uptake.
Malpica-Nieves C, Rivera Y, Rivera-Aponte D, Phanstiel O, Veh R, Eaton M
Biomolecules. 2021; 11(8).
PMID: 34439853
PMC: 8391674.
DOI: 10.3390/biom11081187.
Characterization of HIV-induced remodeling reveals differences in infection susceptibility of memory CD4 T cell subsets in vivo.
Xie G, Luo X, Ma T, Frouard J, Neidleman J, Hoh R
Cell Rep. 2021; 35(4):109038.
PMID: 33910003
PMC: 8202093.
DOI: 10.1016/j.celrep.2021.109038.
Host Defence RNases as Antiviral Agents against Enveloped Single Stranded RNA Viruses.
Li J, Boix E
Virulence. 2021; 12(1):444-469.
PMID: 33660566
PMC: 7939569.
DOI: 10.1080/21505594.2021.1871823.
Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells.
Lee S, Yoon G, Myoung J, Kim S, Ahn D
Emerg Microbes Infect. 2020; 9(1):2169-2179.
PMID: 32969768
PMC: 7580600.
DOI: 10.1080/22221751.2020.1827985.
Extracellular vesicles in virus infection and pathogenesis.
McNamara R, Dittmer D
Curr Opin Virol. 2020; 44:129-138.
PMID: 32846272
PMC: 7755726.
DOI: 10.1016/j.coviro.2020.07.014.
Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.
Wan Q, Song D, Li H, He M
Signal Transduct Target Ther. 2020; 5(1):125.
PMID: 32661235
PMC: 7356129.
DOI: 10.1038/s41392-020-00233-4.
Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges.
Maes M, Colombo G, Schulz R, Siegert S
Neurosci Lett. 2019; 707:134310.
PMID: 31158432
PMC: 6734419.
DOI: 10.1016/j.neulet.2019.134310.
Combining 25-Hydroxycholesterol with an HIV Fusion Inhibitor Peptide: Interaction with Biomembrane Model Systems and Human Blood Cells.
Gomes B, Sanna G, Madeddu S, Hollmann A, Santos N
ACS Infect Dis. 2019; 5(4):582-591.
PMID: 30816690
PMC: 6483092.
DOI: 10.1021/acsinfecdis.8b00321.
Beyond Channel Activity: Protein-Protein Interactions Involving Viroporins.
To J, Torres J
Subcell Biochem. 2018; 88:329-377.
PMID: 29900504
PMC: 7122450.
DOI: 10.1007/978-981-10-8456-0_15.
RNA-Associated Early-Stage Antiviral Factor Is a Major Component of Lv2 Restriction.
Marno K, OSullivan E, Jones C, Diaz-Delfin J, Pardieu C, Sloan R
J Virol. 2017; 91(10).
PMID: 28275184
PMC: 5411576.
DOI: 10.1128/JVI.01228-16.
"Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches.
Malik T, Chauhan G, Rath G, Murthy R, Goyal A
Drug Deliv. 2017; 24(1):608-621.
PMID: 28240046
PMC: 8241151.
DOI: 10.1080/10717544.2016.1228717.
Dynamin-2 Stabilizes the HIV-1 Fusion Pore with a Low Oligomeric State.
Jones D, Alvarez L, Nolan R, Ferriz M, Sainz Urruela R, Massana-Munoz X
Cell Rep. 2017; 18(2):443-453.
PMID: 28076788
PMC: 5263234.
DOI: 10.1016/j.celrep.2016.12.032.
Enhancing Virion Tethering by BST2 Sensitizes Productively and Latently HIV-infected T cells to ADCC Mediated by Broadly Neutralizing Antibodies.
Pham T, Lukhele S, Dallaire F, Perron G, Cohen E
Sci Rep. 2016; 6:37225.
PMID: 27853288
PMC: 5112552.
DOI: 10.1038/srep37225.
Identification of dual-tropic HIV-1 using evolved neural networks.
Fogel G, Lamers S, Liu E, Salemi M, McGrath M
Biosystems. 2015; 137:12-9.
PMID: 26419858
PMC: 4921197.
DOI: 10.1016/j.biosystems.2015.09.007.
Fluorescently-labeled RNA packaging into HIV-1 particles: Direct examination of infectivity across central nervous system cell types.
Xu R, El-Hage N, Dever S
J Virol Methods. 2015; 224:20-9.
PMID: 26272129
PMC: 4577448.
DOI: 10.1016/j.jviromet.2015.07.023.
